Page last updated: 2024-10-22

altretamine and Benign Neoplasms

altretamine has been researched along with Benign Neoplasms in 33 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Research Excerpts

ExcerptRelevanceReference
" Pharmacokinetic studies (100-500 mg m-2) indicated that PMM plasma levels are dose-dependent and that the PMM disposition-phase half-life is prolonged in patients with abnormal liver function."2.65Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies. ( Harrap, KR; Muindi, JR; Newell, DR; Smith, IE, 1983)
"A joint study of advanced gastric cancer was conducted between the Northern California Oncology Group and a Japanese Cooperative Group involving 13 major institutions through the US-Japan Program."1.27[Research project of cancer chemotherapy]. ( Ogawa, M, 1985)
"Pentamethylmelamine is a soluble monodemethylated derivative of hexamethylmelamine."1.26Phase I study of pentamethylmelamine. ( Goldberg, RS; Griffin, JP; Krakoff, IH; McSherry, JW, 1980)
" Reduced bioavailability of PMM and HMM p."1.26Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans. ( Ames, MM; Eagan, RT; Kovach, JS; Powis, G, 1979)
"Its activity is most marked in ovarian cancer, lymphomas, and carcinoma of the cervix; the drug is also active in bronchogenic carcinoma and carcinoma of the breast."1.26Hexamethylmelamine. An evaluation of its role in the therapy of cancer. ( Carter, SK; Legha, SS; Slavik, M, 1976)

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-199027 (81.82)18.7374
1990's4 (12.12)18.2507
2000's1 (3.03)29.6817
2010's1 (3.03)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamandis, P1
Wildenhain, J1
Clarke, ID1
Sacher, AG1
Graham, J1
Bellows, DS1
Ling, EK1
Ward, RJ1
Jamieson, LG1
Tyers, M1
Dirks, PB1
Lin, R1
Elf, S1
Shan, C1
Kang, HB1
Ji, Q1
Zhou, L1
Hitosugi, T1
Zhang, L1
Zhang, S1
Seo, JH1
Xie, J1
Tucker, M1
Gu, TL1
Sudderth, J1
Jiang, L1
Mitsche, M1
DeBerardinis, RJ1
Wu, S1
Li, Y1
Mao, H1
Chen, PR1
Wang, D1
Chen, GZ1
Hurwitz, SJ1
Lonial, S1
Arellano, ML1
Khoury, HJ1
Khuri, FR1
Lee, BH1
Lei, Q1
Brat, DJ1
Ye, K1
Boggon, TJ1
He, C1
Kang, S1
Fan, J1
Chen, J1
Muindi, JR1
Newell, DR1
Smith, IE1
Harrap, KR1
Bruckner, HW1
Schleifer, SJ1
Ogawa, M2
Aabo, K1
Lund, B1
Bogden, AE1
Griffin, W1
Reich, SD1
Costanza, ME1
Cobb, WR1
Braun, DP1
Harris, JE1
Dutcher, JS1
Jones, RB1
Boyd, MR1
Goldberg, RS1
Griffin, JP1
McSherry, JW1
Krakoff, IH1
Van Echo, DA1
Chiuten, DF1
Whitacre, M1
Aisner, J1
Lichtenfeld, JL1
Wiernik, PH1
Benvenuto, JA1
Stewart, DJ1
Benjamin, RS1
Smith, RG1
Loo, TL1
Ajani, JA1
Cabanillas, FF1
Bodey, GP1
D'Incalci, M1
Farina, P1
Sessa, C1
Erba, E1
Madonna, R1
Mangioni, C1
Lee, CR1
Faulds, D1
Coley, HM1
Carter, SK2
Slavik, M2
Ames, MM3
Powis, G1
Kovach, JS2
Eagan, RT1
Winokur, S1
Cavalli, F1
Carter, WH1
Wampler, GL1
Crews, SL1
Howells, R1
Longacre, D1
Donavan, M1
Paladine, W1
Cunningham, T1
Sponzo, R1
Cox, PJ1
Farmer, PB1
Hill, GJ1
Johnson, RO1
Metter, G1
Wilson, WL1
Davis, HL1
Grage, T1
Fletcher, WS1
Golomb, FM1
Cruz, AB1
Legha, SS1
Macdonald, JS1
Richardson, RL1
Moertel, CG1
O'Connell, MJ1
Foster, BJ2
Clagett-Carr, K1
Hoth, D2
Leyland-Jones, B2
Wilman, DE1
Harding, BJ1
Miller, KJ1
McGovern, RM1
ten Bokkel Huinink, WW1
vd Burg, ME1
von Oosterom, AT1
Vermorken, JB1
Veenhof, C1
Roosendaal, K1

Reviews

9 reviews available for altretamine and Benign Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms;

2015
Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.
    Drugs, 1995, Volume: 49, Issue:6

    Topics: Altretamine; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Sa

1995
N-(Hydroxymethyl) melamines.
    General pharmacology, 1997, Volume: 28, Issue:2

    Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Pha

1997
Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
    National Cancer Institute monograph, 1977, Issue:45

    Topics: Altretamine; Animals; Antineoplastic Agents; Asparaginase; Azacitidine; Bleomycin; Cisplatin; Dacarb

1977
[New substances in oncologic therapy].
    Schweizerische medizinische Wochenschrift, 1978, Aug-12, Volume: 108, Issue:32

    Topics: Alkylating Agents; Altretamine; Antimetabolites, Antineoplastic; Cisplatin; Dacarbazine; Doxorubicin

1978
Towards selectivity? Approaches to the design of new anti-tumour agents--II.
    Cancer treatment reviews, 1977, Volume: 4, Issue:2

    Topics: Altretamine; Amino Acids; Antineoplastic Agents; Carbohydrates; Chelating Agents; Colchicine; Colori

1977
Hexamethylmelamine: activity in lymphoma and other tumors.
    Cancer treatment reviews, 1991, Volume: 18 Suppl A

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphoma; Neoplasms

1991
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
    Cancer treatment reports, 1986, Volume: 70, Issue:3

    Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Dogs; Dose-Response Relations

1986
Hexamethylmelamine: a critical review of an active drug.
    Cancer treatment reviews, 1986, Volume: 13, Issue:4

    Topics: Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Humans; Kinet

1986

Trials

5 trials available for altretamine and Benign Neoplasms

ArticleYear
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.
    British journal of cancer, 1983, Volume: 47, Issue:1

    Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Kinetics;

1983
Hexamethylmelamine, vincristine, and methotrexate chemotherapy in advanced neoplasms.
    Cancer treatment reports, 1977, Volume: 61, Issue:5

    Topics: Adult; Aged; Altretamine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Metho

1977
Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation.
    Cancer research, 1990, Jan-01, Volume: 50, Issue:1

    Topics: Altretamine; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans

1990
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
    Cancer treatment reports, 1986, Volume: 70, Issue:3

    Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Dogs; Dose-Response Relations

1986
A pilot study of CHAC-1.
    Cancer treatment reviews, 1985, Volume: 12 Suppl A

    Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cl

1985

Other Studies

20 other studies available for altretamine and Benign Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic

2007
Orthostatic hypotension as a complication of hexamethylmelamine antidepressant interaction.
    Cancer treatment reports, 1983, Volume: 67, Issue:5

    Topics: Aged; Altretamine; Antidepressive Agents; Drug Interactions; Female; Humans; Hypotension, Orthostati

1983
[Current clinical status of new anticancer drugs].
    Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:10

    Topics: Altretamine; Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols;

1983
[Hexamethylmelamine (Hexastat)].
    Ugeskrift for laeger, 1984, Jan-23, Volume: 146, Issue:4

    Topics: Altretamine; Chemical Phenomena; Chemistry; Female; Humans; Neoplasms; Triazines

1984
Predictive testing with the subrenal capsule assay.
    Cancer treatment reviews, 1984, Volume: 11 Suppl A

    Topics: Altretamine; Animals; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Drug Evaluation, Preclin

1984
Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
    Clinical immunology and immunopathology, 1981, Volume: 20, Issue:2

    Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Cell Adhesion; Drug Therapy, Combination; Fluoroura

1981
A sensitive and specific assay for pentamethylmelamine in plasma: applicability to clinical studies.
    Cancer treatment reports, 1980, Volume: 64, Issue:1

    Topics: Aged; Altretamine; Antineoplastic Agents; Female; Gas Chromatography-Mass Spectrometry; Half-Life; H

1980
Phase I study of pentamethylmelamine.
    Cancer treatment reports, 1980, Volume: 64, Issue:12

    Topics: Adult; Altretamine; Dose-Response Relationship, Drug; Drug Evaluation; Electroencephalography; Human

1980
Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
    Cancer treatment reports, 1980, Volume: 64, Issue:12

    Topics: Adult; Aged; Altretamine; Anorexia; Central Nervous System; Dose-Response Relationship, Drug; Drug A

1980
High-performance liquid chromatographic analysis of pentamethylmelamine and its metabolites in biological fluids.
    Journal of chromatography, 1981, Mar-13, Volume: 222, Issue:3

    Topics: Altretamine; Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Kinetics; Metaboli

1981
Phase I trial of pentamethylmelamine.
    Cancer treatment reports, 1982, Volume: 66, Issue:5

    Topics: Altretamine; Antineoplastic Agents; Bone Marrow; Central Nervous System; Drug Evaluation; Humans; Ne

1982
Hexamethylmelamine tissue concentrations in pelvic cancer patients.
    Therapeutic drug monitoring, 1980, Volume: 2, Issue:2

    Topics: Adult; Aged; Altretamine; Female; Humans; Middle Aged; Neoplasms; Ovarian Neoplasms; Triazines

1980
Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
    Cancer research, 1979, Volume: 39, Issue:12

    Topics: Altretamine; Animals; Biological Availability; Drug Evaluation; Humans; Intestinal Absorption; Liver

1979
Recent developments in cancer chemotherapy.
    Journal of the Medical Association of Georgia, 1977, Volume: 66, Issue:9

    Topics: Altretamine; Antineoplastic Agents; Cisplatin; Estramustine; Ethyl Chloride; Humans; Neoplasms; Stre

1977
On determining the levels of treatment to optimize the probability of a favorable response.
    Cancer treatment reports, 1977, Volume: 61, Issue:5

    Topics: Altretamine; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration S

1977
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
    Surgery, gynecology & obstetrics, 1976, Volume: 142, Issue:6

    Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo

1976
Hexamethylmelamine. An evaluation of its role in the therapy of cancer.
    Cancer, 1976, Volume: 38, Issue:1

    Topics: Altretamine; Animals; Breast Neoplasms; Carcinoma, Bronchogenic; Chemical Phenomena; Chemistry; Drug

1976
Prodrugs in cancer chemotherapy.
    Biochemical Society transactions, 1986, Volume: 14, Issue:2

    Topics: Altretamine; Aniline Mustard; Animals; Antineoplastic Agents; Azo Compounds; Biotransformation; Chem

1986
[Research project of cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:3 Pt 2

    Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Cisplatin; Dacarbazine; Etoposide; Hu

1985
Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.
    Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:1

    Topics: Altretamine; Animals; Cell Division; Cell Line; Cyclophosphamide; Humans; Male; Microsomes, Liver; M

1985